Vismodegib
| Vismodegib | |
|---|---|
| Term | Vismodegib |
| Short definition | vismodegib - (pronounced) (VIS-moh-DEH-gib) drug used to treat advanced basal cell carcinoma that has spread to other parts of the body or has come back after surgery. It is also used in patients who cannot be treated with surgery or radiation therapy. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
vismodegib - (pronounced) (VIS-moh-DEH-gib) drug used to treat advanced basal cell carcinoma that has spread to other parts of the body or has come back after surgery. It is also used in patients who cannot be treated with surgery or radiation therapy. It is also being studied in the treatment of other types of cancer. Vismodegib blocks a type of protein involved in tissue growth and repair and can block the growth of cancer cells. It's kind of an antagonist of the Hedgehog signaling pathway. Also called Erivedge and GDC-0449
External links
- Medical encyclopedia article on Vismodegib
- Wikipedia's article - Vismodegib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski